Drugs / Vitamin B5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05701501 | Feb 2023 → Feb 2024 | inflammatory bowel disease | Changhai Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitamin B5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05701501 ↗ |
| Route | Oral | “Vitamin B5 (5mg/tablet) is given orally three times a day, four tablets each time, for 12 weeks.” NCT05701501 ↗ |